Tobramycin (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Tobramycin drug offered from Fresenius Kabi USA, LLC. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: TOBRAMYCIN SULFATE
SUBSTANCE NAME: TOBRAMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2004-11-30
END MARKETING DATE: 0000-00-00


Tobramycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTobramycin from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2004-11-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-305_e605dbf4-347f-4dfd-bc7e-acd6d0862477
PRODUCT NDC: 63323-305
APPLICATION NUMBER: ANDA065122

Other TOBRAMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Tobramycin
Claris Lifesciences Inc.Tobramycin
Fresenius Kabi USA, LLCTobramycin
Hospira, Inc.Tobramycin
Mylan Institutional LLCTobramycin
Pfizer Laboratories Div Pfizer IncTobramycin Sulfate
Teva Parenteral Medicines, Inc.Tobramycin
X-GEN Pharmaceuticals, Inc.Tobramycin
Xellia Pharmaceuticals ApSTobramycin